Immediate evolocumab after a heart attack improves LDL-cholesterol goals but not early cardiovascular outcomes
Immediate initiation of evolocumab after a heart attack significantly improved low-density lipoprotein cholesterol (LDL-C) goal achievement, but an early reduction in all-cause death or unplanned cardiovascular hospitalization ...
Aug 31, 2026
0
7









